Sanotize Research & Development Corporation

Development of anti-microbial medicines from nitric oxide

Based in BC

🤖

AI Overview

With $120K in lobbying spend across 9 quarterly filings, Sanotize Research & Development Corporation is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2024.

$120K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$18K
2023$72K
2024$30K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Budget/Appropriations

  • Legislation related to funding for FDA-required trials of a medical device Consultation with United States Health agencie and Military Health Commands about research and development of medicines and m
  • Seeking funding for Phase III trials of client health product through Congressional appropriations process, specifically the 2023 Omnibus legislation.
  • Effort to Seek funding for Phase II trials of clients product through the appropriations process, specifically the 2023 Omnibus legislation.
  • Seeking US federal funding for Phase III trials of client health product through congressional appropriations process, specifically the 2023 Omnibus legislation.
  • Outreach to Senate HELP committee and House energy & Commerce seeking support for grant research grant efforts with HHS agencies

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.